Wonder what he has got to say about his pet biotech ACST and their dodgy data. But it's only a flesh wound.......optimistic on a second read out & further data mining ( ....because of course the FDA loves that stuff!!) and the subsequent trial.
He couldn't be more transparently conflicted if he tried.
Yet, he raised the PT by 63%? He is the definition of a hack.
Can anyone verify his update besides this tweet?
Oppenheimer $AMRN Stopping of STRENGTH May Weaken Vascepa's Commercial Outlook; Reiterate Underperform$AZN appears to have no plans to ever launch Epanova Removal of Epanova from our $AMRN model leads us to #increase our price target to $13 (vs. prior $8).
Brother...this idiot is quickly eroding any credibility that Oppenheimer has left. Amazing they are letting this dumbass wander around destroying their franchise. Assuming they ever had one.